Sign In
test

Victoria Whyte

Gsk Plc

Assets Managed
$599.153M
Holdings
13
Last Quarter
2026 - Q1
Filed Date
18d ago
Growth Rate
-25.01%(2Q avg: -12.5%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Gsk Plc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 13 positions.

Assets under management

The assets under management (AUM) of Gsk Plc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 599.153M in assets, with a quarterly growth rate of -25.01% and a 2-quarter average growth rate of -12.5%. The portfolio is managed by Victoria Whyte, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
CRSP
Crispr Therapeutics Ag
Recent Activity
25.58%
$153.205M
3.221M shares@ $47.57 avg price
WVE
Wave Life Sciences Ltd
Recent Activity
22.08%
$132.281M
18.246M shares@ $7.26 avg price
BNTX
Biontech Se-adr
Recent Activity
13.2%
$79.088M
889,824 shares@ $88.88 avg price
VIR
Vir Biotechnology Inc
Recent Activity
12.79%
$76.617M
8.551M shares@ $8.97 avg price
IDYA
Ideaya Biosciences Inc
Recent Activity
7.42%
$44.427M
1.333M shares@ $33.33 avg price
LYEL
Lyell Immunopharma Inc
Recent Activity
5.07%
$30.344M
1.513M shares@ $20.07 avg price
CYTK
Cytokinetics Inc
Recent Activity
3.75%
$22.438M
340,434 shares@ $65.92 avg price
SPRO
Spero Therapeutics Inc
Recent Activity
3.59%
$21.506M
9.191M shares@ $2.34 avg price
FULC
Fulcrum Therapeutics Inc
Recent Activity
2.29%
$13.696M
1.786M shares@ $7.67 avg price
CVRX
Cvrx Inc
Recent Activity
1.6%
$9.532M
1.008M shares@ $9.46 avg price

1-10 of 13